RAFAEL HOLDINGS, INC. Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount
RAFAEL HOLDINGS, INC. (RFL) had Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount of $53.00 thousand as of 2025-04-30, per its 10-Q filed 2025-06-11.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions · last filed 2025-06-11
- 2025-04-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $53.00K.
- 2024-10-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $134.00K.
- 2024-07-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $193.00K.
- 2024-04-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $228.00K.
| Period end | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount |
|---|---|
| 2025-04-30 | $53.00K 10-Q · filed 2025-06-11 |
| 2024-10-31 | $134.00K 10-Q · filed 2024-12-11 |
| 2024-07-31 | $193.00K 10-K/A · filed 2024-12-20 |
| 2024-04-30 | $228.00K 10-Q · filed 2024-06-14 |
| 2024-01-31 | $228.00K 10-Q · filed 2024-03-14 |
| 2023-10-31 | $246.00K 10-Q · filed 2023-12-14 |
| 2023-07-31 | $5.00K 10-K · filed 2023-10-30 |
| 2023-04-30 | $7.00K 10-Q · filed 2023-06-13 |
| 2023-01-31 | $8.00K 10-Q · filed 2023-03-14 |
| 2022-10-31 | $10.00K 10-Q · filed 2022-12-13 |
| 2022-01-31 | $11.00K 10-K · filed 2022-10-31 |
| 2021-01-31 | $1.80M 10-Q · filed 2021-03-17 |
| 2020-10-31 | $1.40M 10-Q · filed 2020-12-15 |
| 2020-07-31 | $1.30M 10-K · filed 2020-10-29 |
| 2020-04-30 | $1.30M 10-Q · filed 2020-06-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |